Prevalence of psychotic symptoms in a community-based parkinson disease sample

American Journal of Geriatric Psychiatry

Volumn 20, Issue 2, 2012, Pages 123-132

  MacK, Joel ^a   Rabins, Peter ^a   Anderson, Karen ^b   Goldstein, Susanne ^a,c,e   Grill, Stephen ^a,c   Hirsch, Elaina S ^a   Lehmann, Susan ^a   Little, John T ^a,d   Margolis, Russell L ^a   Palanci, Justin ^a   Pontone, Gregory ^a   Weiss, Howard ^a   Williams, James R ^e   Marsh, Laura ^a,f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c Parkinson's and Movement Disorder Center of Maryland   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Delusions; Hallucinations; Parkinson disease; Psychosis

Indexed keywords

LEVODOPA;

ADULT; AGED; APATHY; ARTICLE; AUDITORY HALLUCINATION; CLINICAL FEATURE; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DELUSION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GERONTOPSYCHIATRY; HAMILTON SCALE; HUMAN; IDIOPATHIC DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; MOTOR DYSFUNCTION; OLFACTORY HALLUCINATION; PARKINSON DISEASE; PREVALENCE; PSYCHIATRIST; PSYCHOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; SCORING SYSTEM; SELF REPORT; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL HALLUCINATION;

EID: 84856217379     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e31821f1b41     Document Type: Article

References (42)

1. Aarsland D, Brønnick K, Alves G, et al: The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80:928-930
2. Weintraub D, Stern MB: Psychiatric complications in Parkinson's disease. Am J Geriatr Psychiatry 2005; 13:844-851
3. Aarsland D, Larsen JP, Tandberg E, et al: Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000; 48:938-942 (Pubitemid 30637303)
4. Goetz CG, Stebbins GT: Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995; 45:669-671
5. Marsh L: Psychosis in Parkinson's disease. Primary Psychiatry 2005; 12:56-62 (Pubitemid 41023308)
6. Sanchez-Ramos JR, Ortoll R, Paulson GW: Visual hallucinations associated with Parkinson's disease. Arch Neurol 1996; 53:1265-1268 (Pubitemid 26425072)
7. Graham JM, Grünewald RA, Sagar HJ: Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 63:434-440 (Pubitemid 27423547)
8. Inzelberg R, Kippervasser S, Korczyn AD: Auditory hallucinations in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 64:533-535 (Pubitemid 28195958)
9. Aarsland D, Larsen JP, Cummings JL, et al: Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999; 56:595-601 (Pubitemid 29218155)
10. Fénelon G, Mahieux F, Huon R, et al: Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000; 123:733-745 (Pubitemid 30162723)
11. Holroyd S, Currie L, Wooten GF: Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70:734-738 (Pubitemid 32554202)
12. Schrag A, Ben-Shlomo Y, Quinn N: How common are complications of Parkinson's disease? J Neurol 2002; 249:419-423 (Pubitemid 34304615)
13. Marsh L, Williams JR, Rocco M et al: Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology 2004; 63:293-300 (Pubitemid 38971129)
14. Merims D, Shabtai H, Korczyn AS, et al: Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. J Neural Transm 2004; 111:1447-1453 (Pubitemid 39468398)
15. Paleacu D, Schechtman E, Inzelberg R: Association between family history of dementia and hallucinations in Parkinson's disease. Neurology 2005; 64:1712-1715 (Pubitemid 40695803)
16. Pacchetti C, Manni R, Zangaglia R, et al: Relationship between hallucinations, delusions and REM behavior disorder in Parkinson's disease. Mov Disord 2005; 20:1439-1448 (Pubitemid 43072652)
17. Williams DR, Warren JD, Lees AJ: Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry 2008; 79:652-655 (Pubitemid 351829436)
18. Papapetropoulos S, Katzen H, Schrag A, et al: A questionnairebased (UM-PDHQ) study of hallucinations in Parkinson's disease. BMC Neurol 2008; 8:21. Available from: http://www.biomedcentral.com/1471-2377/8/21. Accessed December 15, 2009
19. Fénelon G, Soulas T, Zenasni F, et al: The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. Mov Disord 2010; 25(6):755-759
20. Fénelon G, Alves G: Epidemiology of Psychosis in Parkinson's disease. J Neurol Sci 2010; 289:12-17
21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
22. Fernandez HH, Aarsland D, Fénelon G, et al: Scales to assess psychosis in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23:484-500
23. Ravina B, Marder K, Fernandez HH, et al: Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord 2007; 22:1061-1068 (Pubitemid 47067214)
24. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
25. Hughes AJ, Daniel SE, Kilford L, et al: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184
26. Fahn S, Elton RL: Unified Parkinson's disease rating scale, in Recent Developments in Parkinson's Disease. Edited by Fahn S, Marsden CD, Goldstein M, et al Florham, NJ, McMillan Healthcare Information, 1987, pp. 153-164
27. Hoehn MM, Yahr MD: Parkinsonism: onset, progression, and mortality. Neurology 1967; 17:427-442
28. Jenkinson C, Fitzpatrick R, Peto V, et al: The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psychol Health 1997; 12:805-814
29. Lang AE, Lozano AM, Montgomery E, et al: Postventral medial pallidotomy in advanced Parkinson's disease. The New England Journal of Medicine 1997; 337(15):1036-1042 (Pubitemid 27430521)
30. Kessler RC, Andrews G, Mroczek D, et al: The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Intl J Methods in Psychiatric Research 1998; 7(4):171-185
31. Lewis S, Hinchcliffe K, Katona C, et al: An informant interview for the diagnosis of dementia and depression in older adults (IDDGMS). Int J Geriatr Psychiatry 1998; 13:298-309 (Pubitemid 28254579)
32. First MB, Spitzer RL, Gibbon M, : Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) New York, Biometrics Research, New York State Psychiatric Institute, November 2002
33. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
34. Cummings JL: The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology 1997; 48(suppl 6):10-16
35. Leckman JF, Sholomskas D, ThompsonWD, et al: Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982; 39:879-883 (Pubitemid 12042853)
36. Goetz CG, Leurgans S, Pappert EJ, et al: Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology 2001; 57:2078-2082 (Pubitemid 33126877)
37. Goetz CG, Fan W, Leurgans S, et al: The malignant course of "benign hallucinations" in Parkinson's disease. Arch Neurol 2006; 63:713-716
38. Goodwin FK: Psychiatric side effects of levodopa in man. JAMA 1971; 218:1915-1920
39. Damásio A, Lobo-Antunes J, Macedo C: Psychiatric aspects in parkinsonism treated with L-dopa. J Neurol Neurosurg Psychiatry 1971; 34: 502-507
40. Fénelon G, Goetz CG, Karenberg A: Hallucinations in Parkinson disease in the prelevodopa era. Neurology 2006; 66: 93-98 (Pubitemid 43739599)
41. Giladi N, Treves A, Paleacu D, et al: Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000; 107: 59-71 (Pubitemid 30077043)
42. Weintraub D, Morales KH, Duda JE, et al: Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease. Parkinsonism Relat Disord 2006; 12:427-431 (Pubitemid 44416290)